AAPL351.91-0.87 (-0.25%) ▼|ABBV292.82-1.73 (-0.59%) ▼|ABT104.71-2.74 (-2.55%) ▼|ACN239.28-8.42 (-3.40%) ▼|ADBE235.55-10.45 (-4.25%) ▼|AMAT349.23-1.02 (-0.29%) ▼|AMD503.41-0.87 (-0.17%) ▼|AMGN457.93-4.39 (-0.95%) ▼|AMT183.18-7.56 (-3.96%) ▼|AMZN257.89+0.14 (+0.05%) ▲|AVGO341.60+8.20 (+2.46%) ▲|AXP315.78-3.27 (-1.02%) ▼|BA163.91-1.31 (-0.79%) ▼|BAC49.44-0.64 (-1.28%) ▼|BKNG154.46-3.07 (-1.95%) ▼|BLK1,180.67-17.30 (-1.44%) ▼|BMY61.35-1.58 (-2.51%) ▼|BNY149.79-1.90 (-1.25%) ▼|BRK-B586.76-6.09 (-1.03%) ▼|C119.94-1.38 (-1.14%) ▼|CAT570.79+0.30 (+0.05%) ▲|CL99.61-1.38 (-1.37%) ▼|CMCSA25.31-0.29 (-1.13%) ▼|COF186.78-6.44 (-3.33%) ▼|COP139.48-1.04 (-0.74%) ▼|COST1,110.08-3.66 (-0.33%) ▼|CRM194.52-20.31 (-9.45%) ▼|CSCO95.11+0.59 (+0.62%) ▲|CVS85.81-2.78 (-3.14%) ▼|CVX216.13-1.01 (-0.47%) ▼|DE649.23-4.76 (-0.73%) ▼|DHR225.77-4.14 (-1.80%) ▼|DIS116.94-1.76 (-1.48%) ▼|DUK129.84-0.75 (-0.57%) ▼|EMR159.15-1.50 (-0.93%) ▼|FDX319.94-7.71 (-2.35%) ▼|GD355.63-4.06 (-1.13%) ▼|GE326.40+1.22 (+0.38%) ▲|GEV779.91+16.34 (+2.14%) ▲|GILD170.26+2.68 (+1.60%) ▲|GM84.05+0.38 (+0.45%) ▲|GOOG277.60-3.66 (-1.30%) ▼|GOOGL280.20-3.52 (-1.24%) ▼|GS877.52-14.02 (-1.57%) ▼|HD339.01-8.50 (-2.45%) ▼|HON218.96+1.01 (+0.46%) ▲|IBM231.09-11.42 (-4.71%) ▼|INTC55.17-0.27 (-0.49%) ▼|INTU320.79-24.77 (-7.17%) ▼|ISRG430.53-7.22 (-1.65%) ▼|JNJ278.70-3.85 (-1.36%) ▼|JPM329.96-8.25 (-2.44%) ▼|KO98.79-0.69 (-0.69%) ▼|LIN515.11-8.35 (-1.60%) ▼|LLY1,415.55-16.12 (-1.13%) ▼|LMT590.34+5.13 (+0.88%) ▲|LOW220.46-4.47 (-1.99%) ▼|LRCX210.69-0.14 (-0.07%) ▼|MA645.73-15.98 (-2.42%) ▼|MCD275.82+1.15 (+0.42%) ▲|MDLZ66.75-0.79 (-1.17%) ▼|MDT102.32-0.56 (-0.54%) ▼|META618.87-7.54 (-1.20%) ▼|MMM180.88-0.80 (-0.44%) ▼|MO77.46-1.44 (-1.83%) ▼|MRK143.37-1.09 (-0.75%) ▼|MS183.53-2.04 (-1.10%) ▼|MSFT506.24-11.75 (-2.27%) ▼|MU712.42-6.60 (-0.92%) ▼|NEE84.42-0.92 (-1.08%) ▼|NFLX59.68-1.07 (-1.76%) ▼|NKE35.85-2.41 (-6.30%) ▼|NOW92.90-6.47 (-6.51%) ▼|NVDA155.46-0.68 (-0.44%) ▼|ORCL115.00-4.09 (-3.43%) ▼|PEP142.02-4.41 (-3.01%) ▼|PFE28.47-0.39 (-1.35%) ▼|PG171.72-1.30 (-0.75%) ▼|PLTR156.56-3.83 (-2.39%) ▼|PM194.38-1.66 (-0.85%) ▼|QCOM166.67-1.85 (-1.10%) ▼|RTX198.00+3.11 (+1.60%) ▲|SBUX107.49-1.23 (-1.13%) ▼|SCHW91.84-1.10 (-1.18%) ▼|SO93.60-1.04 (-1.10%) ▼|SPG230.24-2.54 (-1.09%) ▼|T22.29-0.07 (-0.31%) ▼|TMO686.79-4.54 (-0.66%) ▼|TMUS167.90-2.11 (-1.24%) ▼|TSLA380.11+0.37 (+0.10%) ▲|TXN295.86+1.65 (+0.56%) ▲|UBER68.81-1.18 (-1.69%) ▼|UNH389.68-22.34 (-5.42%) ▼|UNP297.03-6.68 (-2.20%) ▼|UPS110.31-1.51 (-1.35%) ▼|USB59.18-1.25 (-2.07%) ▼|V416.77-9.69 (-2.27%) ▼|VZ45.93-0.41 (-0.88%) ▼|WFC82.69-2.15 (-2.53%) ▼|WMT127.52-0.89 (-0.69%) ▼|XOM167.21+0.34 (+0.20%) ▲|AAPL351.91-0.87 (-0.25%) ▼|ABBV292.82-1.73 (-0.59%) ▼|ABT104.71-2.74 (-2.55%) ▼|ACN239.28-8.42 (-3.40%) ▼|ADBE235.55-10.45 (-4.25%) ▼|AMAT349.23-1.02 (-0.29%) ▼|AMD503.41-0.87 (-0.17%) ▼|AMGN457.93-4.39 (-0.95%) ▼|AMT183.18-7.56 (-3.96%) ▼|AMZN257.89+0.14 (+0.05%) ▲|AVGO341.60+8.20 (+2.46%) ▲|AXP315.78-3.27 (-1.02%) ▼|BA163.91-1.31 (-0.79%) ▼|BAC49.44-0.64 (-1.28%) ▼|BKNG154.46-3.07 (-1.95%) ▼|BLK1,180.67-17.30 (-1.44%) ▼|BMY61.35-1.58 (-2.51%) ▼|BNY149.79-1.90 (-1.25%) ▼|BRK-B586.76-6.09 (-1.03%) ▼|C119.94-1.38 (-1.14%) ▼|CAT570.79+0.30 (+0.05%) ▲|CL99.61-1.38 (-1.37%) ▼|CMCSA25.31-0.29 (-1.13%) ▼|COF186.78-6.44 (-3.33%) ▼|COP139.48-1.04 (-0.74%) ▼|COST1,110.08-3.66 (-0.33%) ▼|CRM194.52-20.31 (-9.45%) ▼|CSCO95.11+0.59 (+0.62%) ▲|CVS85.81-2.78 (-3.14%) ▼|CVX216.13-1.01 (-0.47%) ▼|DE649.23-4.76 (-0.73%) ▼|DHR225.77-4.14 (-1.80%) ▼|DIS116.94-1.76 (-1.48%) ▼|DUK129.84-0.75 (-0.57%) ▼|EMR159.15-1.50 (-0.93%) ▼|FDX319.94-7.71 (-2.35%) ▼|GD355.63-4.06 (-1.13%) ▼|GE326.40+1.22 (+0.38%) ▲|GEV779.91+16.34 (+2.14%) ▲|GILD170.26+2.68 (+1.60%) ▲|GM84.05+0.38 (+0.45%) ▲|GOOG277.60-3.66 (-1.30%) ▼|GOOGL280.20-3.52 (-1.24%) ▼|GS877.52-14.02 (-1.57%) ▼|HD339.01-8.50 (-2.45%) ▼|HON218.96+1.01 (+0.46%) ▲|IBM231.09-11.42 (-4.71%) ▼|INTC55.17-0.27 (-0.49%) ▼|INTU320.79-24.77 (-7.17%) ▼|ISRG430.53-7.22 (-1.65%) ▼|JNJ278.70-3.85 (-1.36%) ▼|JPM329.96-8.25 (-2.44%) ▼|KO98.79-0.69 (-0.69%) ▼|LIN515.11-8.35 (-1.60%) ▼|LLY1,415.55-16.12 (-1.13%) ▼|LMT590.34+5.13 (+0.88%) ▲|LOW220.46-4.47 (-1.99%) ▼|LRCX210.69-0.14 (-0.07%) ▼|MA645.73-15.98 (-2.42%) ▼|MCD275.82+1.15 (+0.42%) ▲|MDLZ66.75-0.79 (-1.17%) ▼|MDT102.32-0.56 (-0.54%) ▼|META618.87-7.54 (-1.20%) ▼|MMM180.88-0.80 (-0.44%) ▼|MO77.46-1.44 (-1.83%) ▼|MRK143.37-1.09 (-0.75%) ▼|MS183.53-2.04 (-1.10%) ▼|MSFT506.24-11.75 (-2.27%) ▼|MU712.42-6.60 (-0.92%) ▼|NEE84.42-0.92 (-1.08%) ▼|NFLX59.68-1.07 (-1.76%) ▼|NKE35.85-2.41 (-6.30%) ▼|NOW92.90-6.47 (-6.51%) ▼|NVDA155.46-0.68 (-0.44%) ▼|ORCL115.00-4.09 (-3.43%) ▼|PEP142.02-4.41 (-3.01%) ▼|PFE28.47-0.39 (-1.35%) ▼|PG171.72-1.30 (-0.75%) ▼|PLTR156.56-3.83 (-2.39%) ▼|PM194.38-1.66 (-0.85%) ▼|QCOM166.67-1.85 (-1.10%) ▼|RTX198.00+3.11 (+1.60%) ▲|SBUX107.49-1.23 (-1.13%) ▼|SCHW91.84-1.10 (-1.18%) ▼|SO93.60-1.04 (-1.10%) ▼|SPG230.24-2.54 (-1.09%) ▼|T22.29-0.07 (-0.31%) ▼|TMO686.79-4.54 (-0.66%) ▼|TMUS167.90-2.11 (-1.24%) ▼|TSLA380.11+0.37 (+0.10%) ▲|TXN295.86+1.65 (+0.56%) ▲|UBER68.81-1.18 (-1.69%) ▼|UNH389.68-22.34 (-5.42%) ▼|UNP297.03-6.68 (-2.20%) ▼|UPS110.31-1.51 (-1.35%) ▼|USB59.18-1.25 (-2.07%) ▼|V416.77-9.69 (-2.27%) ▼|VZ45.93-0.41 (-0.88%) ▼|WFC82.69-2.15 (-2.53%) ▼|WMT127.52-0.89 (-0.69%) ▼|XOM167.21+0.34 (+0.20%) ▲|
13.7 C
New York
Wednesday, November 18, 2026

Tag: company

Likang Life Sciences Showcases Personalized Cancer Immunotherapy and Global Ambitions at Abu Dhabi Future Health Summit 2026

BEIJING, Oct. 24, 2026 /PRNewswire/ -- Likang Life Sciences ("Likang"), a biotechnology company advancing AI-enabled personalized cancer immunotherapies, sponsored and exhibited at the Abu Dhabi...

IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER

Nearly 80% of Patients Were Alive at One Year Versus 53% with IMFINZI Alone and Progression-Free Survival More Than TripledLate-Breaking Phase 3 DeLLphi-305 Results Presented in...

Swanson Vitamins Launches Swanson Vitamins Nexus Pro to Champion Registered Dietitians and Licensed Nutritionists at Every Stage of Their Careers

New network for health and nutrition professionals offers CPEU-accredited continuing education, profession-wide promotion, practicum support and exam scholarshipsFARGO, N.D., Oct. 24, 2026 /PRNewswire/ --...

The Ultimate Send-off to Summer: CSTS Debuts Global Entertainment IP PremierX at New York’s Pier 17, Ushering in a New Era of Live Entertainment

NEW YORK, Oct. 24, 2026 /PRNewswire/ -- CSTS Enterprises ('CSTS'), a New York-based sports, entertainment, integrated media and travel technology group, today announced the...

Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk...

New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ADT compared with immediate surgeryTwice as...

Likang Life Sciences Showcases Personalized Cancer Immunotherapy and Global Ambitions at Abu Dhabi Future Health Summit 2026

BEIJING, Oct. 24, 2026 /PRNewswire/ -- Likang Life Sciences ("Likang"), a biotechnology company advancing AI-enabled personalized cancer immunotherapies, sponsored and exhibited at the Abu Dhabi...

Likang Life Sciences Showcases Personalized Cancer Immunotherapy and Global Ambitions at Abu Dhabi Future Health Summit 2026

BEIJING, Oct. 24, 2026 /PRNewswire/ -- Likang Life Sciences ("Likang"), a biotechnology company advancing AI-enabled personalized cancer immunotherapies, sponsored and exhibited at the Abu Dhabi...

Bio-Thera Announces Promising Clinical Data for BAT8008 in Combination with BAT1308 in First-Line Non-Small Cell Lung Cancer at ESMO 2026

GUANGZHOU, China, Oct. 24, 2026 /PRNewswire/ -- Bio-Thera Solutions, Ltd. (688177.SH), a commercial-stage biopharmaceutical company developing innovative therapies and biosimilars, today announced the presentation...

Phase II Results of Sacituzumab Tirumotecan (sac-TMT) plus Pembrolizumab in Advanced Urothelial Carcinoma Presented at 2026 ESMO

CHENGDU, China, Oct. 24, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 European Society...

Lilly presents first clinical data in platinum-sensitive ovarian cancer for its investigational, next-generation, FRα-targeting ADC at ESMO 2026

Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% disease control rate, with similar activity observed across...

/C O R R E C T I O N – DigitalXForce Corporation/

In the news release, DigitalXForce Scores Triple Win: IDC MarketScape Leader Recognition, Institutional Investment from Arsenal Equity Group and 514% Growth, issued 21-Oct-2026 by...

19th EU-China Business Meeting Concludes! Third-Generation Triple-Helix Biomimetic Collagen Medical Devices Make Their Global Debut, Highlights from the Event

CHENGDU, China, Oct. 24, 2026 /PRNewswire/ -- At the 19th EU-China Business Meeting, co-hosted by the China Chamber of International Commerce (CCOIC) and the...

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Research Will Use Lunit's AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment BiologySEOUL, South Korea, Oct. 24,...

DENARIUS METALS FILES TORAL PROJECT TECHNICAL REPORT ON SEDAR+

TORONTO, Oct. 23, 2026 /CNW/ -- Denarius Metals Corp. (Cboe CA: DMET) (OTCQX: DNRSF) ("Denarius Metals" or "the Company") announced today the filing of...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompany